Only two in ten people diagnosed with brain cancer will survive for at least five years, a figure that has barely improved in the last 30 years. Due to the blood-brain barrier and the risk of damaging normal brain tissue, brain cancer treatments are complex and multidisciplinary. Despite advances in surgical techniques, radiotherapy and chemotherapeutics, brain tumours remain challenging to treat. Hence, image-guided microbeam radiation therapy (MRT) with nanoparticle enhancement is being investigated for the treatment of brain cancer in animal models.Read More
Breast cancer, the most common cancer in women worldwide, may one day be treated using the venom of the European honeybee.
Dr Ciara Duffy from Western Australia’s Harry Perkins Institute of Medical Research has found that venom from honeybees can rapidly kill aggressive and hard-to-treat breast cancer cells. NCRIS-enabled facilities at the Centre for Microscopy, Characterization and Analysis (CMCA), UWA, were integral to the research, published recently in the journal Nature Precision Oncology.Read More